top of page
Glass Ceiling


Our leadership team has a proven track record across drug discovery, development and commercialization

Sue_Dillon Fall 2020 Vedanta Head Shot_edited.jpg
Susan Dillon, PhD

Co-founder, President and Chief Executive Officer

Aro Biotherapeutics Mitte Doyle.jpg
Mittie Doyle, MD, FACR

Chief Medical Officer

Aro Biotherapeutics Mark Laurenzi.jpg
Mark Laurenzi

​Chief Administrative Officer & Vice President, Legal

Aro Biotherapeutics Adam Dinerman_.jpg
Adam Dinerman, PhD

Executive Director, Head of Chemistry, Manufacturing and Controls (CMC)

Aro Biotherapeutics Karyn O’Neil, PhD.jpg
Karyn O’Neil, PhD

Co-founder and Chief Scientific Officer

Aro Biotherapeutics Sukumar Sakamuri.jpg
Sukumar Sakamuri, PhD

Chief Technology Officer

Aro Biotherapeutics Jeffrey Staiger.jpg
Jeffrey Staiger

Senior Vice President of Finance and Business Development

Scott Greenberg Head Shot.jpg
Scott Greenberg

Chief Operating Officer

ARO leadership Steve Nadler copy.jpg
Steven Nadler, PhD

Senior Vice President of Discovery and Translational Research

Aro Biotherapeutics Michael Tortorici.jpg
Michael Tortorici, PharmD, PhD

Vice President of Clinical Pharmacology and Non-Clinical Development

bottom of page